Display search results for ** instead (5 products)
25 Oct 2017  |  North America
By 2025, Data Monetisation is Expected to Unravel ~$33 Billion in Opportunity for OEMs, with the Potential to Monetise $100 per Car Across 140 Unique Use Cases
This study analyses the strategies, growth analysis, competitive landscape, business models, and future focus areas of OEMs, data aggregators, usage-based insurance (UBI) companies, and tier 1 suppliers. OEMs, tier 1s, insurance companies, and data aggregators must focus on data services around smart mobility, connected cars, and autonomous vehicle...
20 Oct 2017  |  North America
Gain a Competitive Advantage Using Insights
This in-depth study of 1,934 IT decision makers was designed to measure the current use and future decision making behavior toward information technology (IT) around the globe and across verticals. More than half of the respondents were C-Level executives. IT solutions covered include Enterprise Mobility Management, eCommerce/mCommerce, Unified Com...
03 Mar 2017  |  North America
Digitalization Spending to Grow Rapidly to $82.01 Billion in 2020
Research Scope In 2015, automotive industry investments in key focus areas were about $19.57 billion. Growing digitalization and advancements in technology will increase the investments to $82.01 billion by 2020. The rapid pace of digitalization is transforming the component hardware-driven automotive sector to a software and solutions-focused ind...
24 Aug 2016  |  North America
A Deep Dive into Twelve Prominent Solutions
Not all customers, locations or users will move to cloud communications services. There are valid reasons to deploy UC solution on the customer premises. This Buyers' Guide overviews capabilities available with the flagship SMB platforms offered by North America's leading UC platform vendors. Details include: development direction, scale, performan...
04 Jul 2016  |  North America
The Next Generation of Cancer Therapies
Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...
USD 6,000.00 save 25 %